Related Experiment Video
Updated: Jun 1, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Restrictive management of neonatal polycythemia
Iris Morag1, Tzipora Strauss, Daniel Lubin
1Department of Neonatology, Mayanei HaYeshua Medical Center, Bnei Brak, Israel. irismorag@gmail.com
American Journal of Perinatology
|June 14, 2011
Summary
A restrictive treatment protocol for neonatal polycythemia, focusing on hydration and feeding adjustments, showed no increased short-term complications compared to traditional partial exchange transfusion (PET). This approach is safe for asymptomatic infants.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
Background:
- Neonatal polycythemia is commonly treated with partial exchange transfusion (PET), but its necessity is debated.
- Evaluating risks associated with alternative management strategies is crucial for optimizing neonatal care.
Purpose of the Study:
- To assess the short-term complication risks of a restrictive treatment protocol for neonatal polycythemia.
- To compare outcomes between different management strategies based on hematocrit levels and symptoms.
Main Methods:
- Retrospective cross-sectional analytical study involving 190 neonates diagnosed with polycythemia.
- Three management groups were defined based on hematocrit levels: no treatment (65-69%), conservative management (70-75%), and PET (≥76% or symptomatic).
- Complication rates, including seizures, necrotizing enterocolitis, and thrombosis, were analyzed.
Main Results:
- The overall short-term complication rate was 15% (28 neonates).
- No seizures, necrotizing enterocolitis, or thrombosis occurred in any neonates.
- Partial exchange transfusion (PET) was performed in 16% of neonates.
- No significant differences in early neonatal morbidities or hospitalization length were observed between groups.
Conclusions:
- A restrictive treatment protocol for asymptomatic neonatal polycythemia is not associated with increased short-term complications.
- Conservative management appears safe and effective, potentially reducing the need for invasive procedures like PET.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:27Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...